Team:Marburg:Project:Notebook:August
From 2014.igem.org
(Difference between revisions)
Line 36: | Line 36: | ||
</fieldset> | </fieldset> | ||
</div> | </div> | ||
+ | |||
+ | |||
+ | <!-- ROMAN --> | ||
+ | |||
+ | <!-- 04.08.14 --> | ||
+ | |||
+ | <div class="notebooky-entry"> | ||
+ | <h2 class="title"> | ||
+ | <a name="04.08.2014">04.08.2014</a> | ||
+ | </h2> | ||
+ | <fieldset class="exp14"> | ||
+ | <legend><a name="exp14.68">14.68 Crystallization of Arc1p-C</a></legend> | ||
+ | <div class="aim"> | ||
+ | <p>Aim: Crystallize the Arc1p-C-single domain</p> | ||
+ | </div> | ||
+ | <div class="exp-content"> | ||
+ | <p>For the experiments the sitting drop method in SWISSCI MRC 2 well crystallization plates with a drop size of 1 µL was used (1:1 mixture of protein and crystallization solution) with an reservoir volume of 50 µL. Crystals of Arc1p-C-single were obtained | ||
+ | by room temperature and at 6 mg/mL protein concentration after 1 week in 0.1 M MES, pH 6.0, 10% (v/v) glycerol, 30% (w/v) PEG 600 and 5% (w/v) PEG 1000. To collect data the crystals | ||
+ | were flash frozen in liquid nitrogen and measured at the European Synchrotron Radiation Facility (ESRF) in Grenoble, France at beamline ID23-1. The structure of Arc1p-C-single | ||
+ | was determined by molecular replacement (MR) using the crystal structure of human Arc1p-C (PDB ID: 1FL0).</p> | ||
+ | </div> | ||
+ | </fieldset> | ||
+ | </div> | ||
+ | |||
+ | <!-- ROMAN --> | ||
+ | |||
<!-- 05.08.14 --> | <!-- 05.08.14 --> | ||
Line 165: | Line 191: | ||
</div> | </div> | ||
</fieldset> | </fieldset> | ||
+ | |||
+ | |||
+ | <!-- ROMAN --> | ||
+ | |||
+ | <fieldset class="exp14"> | ||
+ | <legend><a name="exp14.69">14.69 tRNA<sup>Phe</sup> assay</a></legend> | ||
+ | <div class="aim"> | ||
+ | <p>Aim: Measure aminoacylation levels</p> | ||
+ | </div> | ||
+ | <div class="exp-content"> | ||
+ | <p>To measure aminoacylation of tRNA<sup>Phe</sup> the components were mixed.</p> | ||
+ | <table width="100%" border="1"> | ||
+ | <tr> | ||
+ | <th scope="col">Content</th> | ||
+ | <th scope="col">Final concentration</th> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <th scope="row">Dialysis-buffer</th> | ||
+ | <td>ad 250 µL</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <th scope="row">DTT</th> | ||
+ | <td>1 mM</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <th scope="row">MgCl<sub>2</sub></th> | ||
+ | <td>20 mM</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <th scope="row">KCl</th> | ||
+ | <td>10 mM</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <th scope="row">tRNA<sup>Phe</sup></th> | ||
+ | <td>10 µM</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <th scope="row">L- or D-Phenylalanine</th> | ||
+ | <td>1 mM</td> | ||
+ | </tr> | ||
+ | <tr> | ||
+ | <th scope="row">catalytic fusion Protein</th> | ||
+ | <td>10 µM</td> | ||
+ | </tr> | ||
+ | </table> | ||
+ | <p>After mixing, reaction was initiated by the addition of 2 mM ATP and then incubated for 1 to 60 min by 37 °C and 350 rpm. Assays were stopped by the addition of 25 µL 3 M sodium acetate solution. Afterwards tRNAs were precipitated with ethanol. Dissolved pellets were further purified using size-exclusion columns. The elution fraction was split into two aliquots. One samples was treated with 0.2 M NaOH (final concentration: 10 mM) and incubated at 50 °C for 10 min, while the other aliquot was kept on ice. The base treated sample was again acidified by the addition of 3 M sodium acetate (pH 5.2, final concentration: 300 mM). The volume of the untreated sample was adjusted using 2 mM sodium acetate (pH 5.2). Subsequently, both samples were subjected to LCMS analysis using 100 µL for injection.</p> | ||
+ | </div> | ||
+ | </fieldset> | ||
+ | |||
+ | <!-- ROMAN --> | ||
+ | |||
+ | |||
</div> | </div> | ||
Revision as of 00:16, 16 October 2014
Notebook: August